Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Engineering thrombin to function as a selective anticoagulant by identification of a Glu to Lys mutation that converts thrombin into an exclusive protein C activator. Tsiang, M., Li, W. X., Jain, A. K., Mao, C. T., Dunn, K. E., MATSUMURA, S. Y., Coutre, S., Leung, L. L., Paborsky, L. R., Gibbs, C. S. AMER SOC HEMATOLOGY. 1995: 1779–79
View details for Web of Science ID A1995TH91001781